drugset / Trial / NCT00690794

Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT00690794

Phase 3 Completed 726 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of the study is to compare two ophthalmic solutions in patients with open-angle glaucoma or ocular hypertension.

Timeline

Start
2008-07
Primary completion
2009-05
Completion
2009-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator Latanoprost Small molecule 0.005 % Topical
Subject Travoprost Other / unclassified 0.004 % Topical